Skip Nav Destination
Issues
GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
Diabetes October 2000, Vol.49, 1621-1626. doi:https://doi.org/10.2337/diabetes.49.10.1621
Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase.
Diabetes October 2000, Vol.49, 1627-1634. doi:https://doi.org/10.2337/diabetes.49.10.1627
Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization.
Diabetes October 2000, Vol.49, 1635-1642. doi:https://doi.org/10.2337/diabetes.49.10.1635
Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice.
Diabetes October 2000, Vol.49, 1643-1648. doi:https://doi.org/10.2337/diabetes.49.10.1643
5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Diabetes October 2000, Vol.49, 1649-1656. doi:https://doi.org/10.2337/diabetes.49.10.1649
Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group.
Diabetes October 2000, Vol.49, 1657-1665. doi:https://doi.org/10.2337/diabetes.49.10.1657
Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat.
Diabetes October 2000, Vol.49, 1666-1670. doi:https://doi.org/10.2337/diabetes.49.10.1666
Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans.
V Gmyr; J Kerr-Conte; S Belaich; B Vandewalle; E Leteurtre; M C Vantyghem; M Lecomte-Houcke; C Proye; J Lefebvre; F Pattou
Diabetes October 2000, Vol.49, 1671-1680. doi:https://doi.org/10.2337/diabetes.49.10.1671
Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells.
Diabetes October 2000, Vol.49, 1681-1690. doi:https://doi.org/10.2337/diabetes.49.10.1681
Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes.
Diabetes October 2000, Vol.49, 1691-1699. doi:https://doi.org/10.2337/diabetes.49.10.1691
Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
H Sakoda; T Ogihara; M Anai; M Funaki; K Inukai; H Katagiri; Y Fukushima; Y Onishi; H Ono; M Fujishiro; M Kikuchi; Y Oka; T Asano
Diabetes October 2000, Vol.49, 1700-1708. doi:https://doi.org/10.2337/diabetes.49.10.1700
Activity of the glycosylating enzyme, core 2 GlcNAc (beta1,6) transferase, is higher in polymorphonuclear leukocytes from diabetic patients compared with age-matched control subjects: relevance to capillary occlusion in diabetic retinopathy.
Diabetes October 2000, Vol.49, 1724-1730. doi:https://doi.org/10.2337/diabetes.49.10.1724
Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis.
Diabetes October 2000, Vol.49, 1731-1739. doi:https://doi.org/10.2337/diabetes.49.10.1731
Gene encoding the catalytic subunit p110beta of human phosphatidylinositol 3-kinase: cloning, genomic structure, and screening for variants in patients with type 2 diabetes.
M Kossila; M Sinkovic; P Kärkkäinen; M O Laukkanen; R Miettinen; J Rissanen; P Kekäläinen; J Kuusisto; S Ylä-Herttuala; M Laakso
Diabetes October 2000, Vol.49, 1740-1743. doi:https://doi.org/10.2337/diabetes.49.10.1740
NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans.
Diabetes October 2000, Vol.49, 1744-1747. doi:https://doi.org/10.2337/diabetes.49.10.1744
